Mingfeng Han
Impact in
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 0.5%
- Long-Term Effects of COVID-19
Papers in ⓘ
-
- COVID-19 Clinical Research Studies 15
- SARS-CoV-2 and COVID-19 Research 14
- SARS-CoV-2 detection and testing 4
-
- Long-Term Effects of COVID-19 8
- Co-authors
- Xiuyong Li (8 shared papers)Wei Sun (2 shared papers)Yun Yang (1 shared paper)Haiming Wei (1 shared paper)Xiao‐Hua Zhang (1 shared paper)Aijun Pan (1 shared paper)Dongsheng Wang (1 shared paper)Binqing Fu (1 shared paper)
- Journals
- Frontiers in Medicine (3 papers)Aging (2 papers)Journal of Medical Virology (2 papers)Journal of Inflammation Research (2 papers)Journal of Functional Foods (1 paper)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Mingfeng Han
26 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Infectious Diseases 2.6k
- Neurology 1.5k
- Clinical Psychology 620
- Pharmacology 191
- Complementary and alternative medicine 153
Countries citing papers authored by Mingfeng Han
This map shows the geographic impact of Mingfeng Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingfeng Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingfeng Han more than expected).
Fields of papers citing papers by Mingfeng Han
This network shows the impact of papers produced by Mingfeng Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingfeng Han. The network helps show where Mingfeng Han may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingfeng Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effective treatment of severe COVID-19 patients with tocilizumab Hit paper breakdown → | 2020 | 1874 |
| 2 | Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19 Hit paper breakdown → | 2020 | 742 |
| 3 | [Mental health survey of medical staff in a tertiary infectious disease hospital for COVID-19]. Hit paper breakdown → | 2020 | 507 |
| 4 | Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial Hit paper breakdown → | 2020 | 338 |
| 5 | 2020 | 167 | |
| 6 | 2020 | 44 | |
| 7 | 2021 | 31 | |
| 8 | 2020 | 25 | |
| 9 | 2020 | 20 | |
| 10 | 2018 | 20 | |
| 11 | 2020 | 18 | |
| 12 | 2020 | 15 | |
| 13 | 2020 | 14 | |
| 14 | 2022 | 13 | |
| 15 | 2023 | 6 | |
| 16 | 2020 | 5 | |
| 17 | 2024 | 3 | |
| 18 | 2024 | 3 | |
| 19 | 2021 | 3 | |
| 20 | 2025 | 2 |
About Mingfeng Han
Mingfeng Han is a scholar working on Infectious Diseases, Neurology, Pulmonary and Respiratory Medicine, Epidemiology and Physiology, having authored 29 papers that have together received 3.9k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (15 papers), SARS-CoV-2 and COVID-19 Research (14 papers), Long-Term Effects of COVID-19 (8 papers), SARS-CoV-2 detection and testing (4 papers), COVID-19 diagnosis using AI (2 papers), Respiratory Support and Mechanisms (2 papers), Asthma and respiratory diseases (2 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers). The work is most often cited by research in Infectious Diseases (2.6k citations), Neurology (1.5k citations), Clinical Psychology (620 citations), Pharmacology (191 citations) and Complementary and alternative medicine (153 citations). Mingfeng Han has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Xiuyong Li, Wei Sun, Yun Yang, Haiming Wei, Xiao‐Hua Zhang, Aijun Pan, Dongsheng Wang, Binqing Fu, Xiaohu Zheng and Yonggang Zhou. Their work appears in journals such as Frontiers in Medicine, Aging, Journal of Medical Virology, Journal of Inflammation Research and Journal of Functional Foods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.